| BC | breast cancer |
| CDK | cyclin-dependent kinase |
| CDKN2A | cyclin-dependent kinase inhibitor 2A |
| DSB | double-strand break |
| ER | estrogen receptor |
| FITC | fluorescein isothiocyanate |
| HER2 | human epidermal growth factor receptor 2 |
| NSCLC | non-small cell lung cancer |
| PARP | poly (ADP-ribose) polymerase |
| PR | progesterone receptor |
| RB | retinoblastoma susceptibility gene |
| RBE | relative biological effectiveness |
| RIPA | radio-immunoprecipitation assay |
| SDS-PAGE | sodium dodecyl sulfate-polyacrylamide gel electrophoresis |
| SF | survival fraction |
| siRNA | small interfering ribonucleic acid |
| SOBP | spread-out Bragg peak |
| TNBC | triple-negative breast cancer |